The 4th Editorial Board Meeting of Metabolism and Target Organ Damage Held Successfully
On September 4, 2024, Metabolism and Target Organ Damage (M&TOD), led by Editor-in-Chief Prof. Amedeo Lonardo, successfully held its fourth online Editorial Board Meeting. The event marked a major milestone—the journal's first Impact Factor of 3.9—and focused on strategies for future development.
In his remarks, Prof. Lonardo expressed sincere appreciation to the editorial team, noting that achieving an Impact Factor of 3.9 within only three years of launch reflects the journal's rapid growth and recognition in the field of metabolic diseases and target organ damage.
Looking forward, the board set a clear goal of further improving the journal's quality and academic influence, with the ambition of reaching the Q1 quartile in the near future. Members shared valuable suggestions, including leveraging artificial intelligence in editorial workflows, upholding rigorous pre-check standards, and hosting author-focused webinars to strengthen scientific writing.
This meeting not only celebrated M&TOD's recent achievements but also defined its next steps for sustained growth. The journal reaffirms its commitment to excellence, international standards, and professionalism, with the vision of becoming a leading platform for research on metabolism and target organ damage.
Attendee list (in alphabetical order of surnames within the same position)
| Position | Name | Institution |
|---|---|---|
| Editor-in-Chief | Amedeo Lonardo | Metabolic Syndrome Unit, University of Modena (–2023), Modena, Italy. |
| Associate Editors | Luigi Angrisani | Department of Public Health, School of Medicine and Surgery – "Federico II" University of Naples, Italy. |
| Juan Pablo Arab | Department of Medicine, Division of Gastroenterology and Hepatology, Western University, Ontario, Canada. | |
| Ralf Weiskirchen | Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, Aachen, Germany. | |
| Editorial Board Members | Lynn H. Gerber | Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, VA, United States. College of Public Health, George Mason University, Fairfax, VA, United States. |
| Francesco Giorgino | Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy. | |
| Yong-ho Lee | Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea. | |
| Mariana Verdelho Machado | Department of Gastroenterology and Hepatology, Hospital de Vila Franca de Xira, Lisbon, Portugal. | |
| Marcello Persico | Department of Medicine, Surgery and Dentistry, "Scuola Medica Salernitana," University of Salerno, Baronissi, Italy. | |
| Vincent Wai Sun Wong | Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong. | |
| Huiping Zhou | Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA, USA. | |
| Junior Editorial Board Members | Josh Bilson | Endocrinology & Metabolism, School of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK. |
| Marco Infante | UniCamillus, Saint Camillus International University of Health Sciences, Rome, Italy. | |
| Jimmy Lai | Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China. | |
| Natalia Rosso | The Italian Liver Foundation and Department of Medical Sciences, University of Trieste, Trieste, Italy. |
Editor: Alani Luo
Language Editor: Emma Chen
Production Editor: Ting Xu
Respectfully Submitted by the Editorial Office of Metabolism and Target Organ Damage
